Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × alectinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Neoplasms 4 Lung Neoplasms 4 Solid Tumors 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Hematologic Neoplasms 1 Genomic Instability 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 ALK+ Advanced NSCLC 1

Interventions

Carboplatin 8 pembrolizumab 6 Radiotherapy 5 Pemetrexed 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Paclitaxel 3 Nivolumab 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Platinum 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1 trametinib 1 sotorasib 1 rucaparib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡